| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |